BiotechTube
Gyros Protein Technologies

Gyros Protein Technologies

Uppsala, Sweden· Est.
gyrosproteintechnologies.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Gyros Protein Technologies is a provider of automated solutions for the proteomics and diagnostics sectors, operating from Uppsala, Sweden. Its core offering is the Gyrolab platform, a microfluidic system designed to automate and miniaturize immunoassays, significantly improving throughput and data quality for applications like pharmacokinetics, immunogenicity, and biomarker analysis. The company serves a global customer base in biopharmaceutical R&D and production, offering integrated systems, consumables, kits, and custom assay development services to enhance productivity in regulated and non-regulated bioanalysis.

ProteomicsDiagnostics

Technology Platform

Gyrolab microfluidic immunoassay platform using nanoliter-scale affinity flow-through technology on compact discs (CDs) for full automation; PurePep series of peptide synthesizers for solid-phase peptide synthesis (SPPS).

Funding History

1
UndisclosedUndisclosed

Opportunities

The rapid growth of biologics, biosimilars, and complex modalities (ADCs, viral vectors) creates sustained demand for robust, automated bioanalytical solutions.
The industry-wide push for lab automation and miniaturization to reduce costs and increase throughput aligns perfectly with the Gyrolab value proposition.
Expansion into supporting new therapeutic areas like cell and gene therapy presents a significant growth avenue.

Risk Factors

Faces intense competition from large, diversified life science tool companies and other niche automation platforms.
Success depends on convincing labs to switch from entrenched, lower-cost manual ELISA methods, which presents an adoption hurdle.
As a provider to the biopharma sector, revenue is susceptible to downturns in R&D funding and capital expenditure cycles.

Competitive Landscape

Competes in the automated immunoassay segment against large players like Thermo Fisher Scientific, Agilent Technologies, and PerkinElmer, as well as other specialized automation providers. In the peptide synthesis instrument market, it competes with companies like CEM Corporation and Biotage. Its differentiation lies in its unique microfluidic CD-based approach, offering miniaturization and full workflow automation in a single system.

More companies in Proteomics & Protein Engineering →More companies in Sweden →